Complete report $8,500. DataPack test volumes, sales forecasts, supplier shares $5,500.
This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays:
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2014 Analysis of the Global Therapeutic Drug Monitoring TDM Market: US, Europe France, Germany, Italy, Spain, UK, Japan is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 313 pages and 83 tables
SIMILAR MARKET STUDIES
This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for cancer diagnostic testing. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 119 pages
March 2017 | $0 | View Details >>
This new report from VPGMarketResearch.com provides strategic assessments of major suppliers of hematology and flow cytometry instruments and reagents, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 30 pages
July 2016 | $0 | View Details >>
Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
"This unique seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. strong Highlight Business and technological trends in seven major markets Five and ten-year test volume and sales forecasts Market shares of ...
June 2014 | $15900 | View Details >>
The United States Cholesterol Rapid Tests Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the Cholesterol Rapid Tests industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cholesterol Rapid Tests market analysis ...
January 2016 | $3800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research